Hamburg AoRtic Valve cOhoRt

NCT04227002 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2020-01-13

No results posted yet for this study

Summary

The primary aim of the study is to identify the optimal treatment modality for patients with aortic valve disease, incorporating the individual patient's risk profile and anticipated clinical outcomes. This includes the association of demographic factors, procedural data and biomarkers with clinical outcome in a prospective fashion.

Conditions

  • Aortic Valve Stenosis

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Moritz Seiffert, MD · University Heart Center Hamburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2039-09-01
Completion
2049-09-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04227002 on ClinicalTrials.gov